[go: up one dir, main page]

AU2003207528A1 - Method of detecting t-cell proliferation for diagnosis of diseases by gene array - Google Patents

Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Info

Publication number
AU2003207528A1
AU2003207528A1 AU2003207528A AU2003207528A AU2003207528A1 AU 2003207528 A1 AU2003207528 A1 AU 2003207528A1 AU 2003207528 A AU2003207528 A AU 2003207528A AU 2003207528 A AU2003207528 A AU 2003207528A AU 2003207528 A1 AU2003207528 A1 AU 2003207528A1
Authority
AU
Australia
Prior art keywords
diagnosis
diseases
detecting
cell proliferation
gene array
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003207528A
Other versions
AU2003207528A8 (en
Inventor
Shong Cheng
Ying Zang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAXX GENETECH CO Ltd
Original Assignee
MAXX GENETECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAXX GENETECH CO Ltd filed Critical MAXX GENETECH CO Ltd
Publication of AU2003207528A1 publication Critical patent/AU2003207528A1/en
Publication of AU2003207528A8 publication Critical patent/AU2003207528A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003207528A 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array Abandoned AU2003207528A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNHK02100156.8 2002-01-09
HK02100156 2002-01-09
PCT/US2003/000882 WO2003059155A2 (en) 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Publications (2)

Publication Number Publication Date
AU2003207528A1 true AU2003207528A1 (en) 2003-07-30
AU2003207528A8 AU2003207528A8 (en) 2003-07-30

Family

ID=10945400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003207528A Abandoned AU2003207528A1 (en) 2002-01-09 2003-01-08 Method of detecting t-cell proliferation for diagnosis of diseases by gene array

Country Status (3)

Country Link
CN (1) CN1688708A (en)
AU (1) AU2003207528A1 (en)
WO (1) WO2003059155A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101431312B1 (en) 2003-06-27 2014-08-20 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Method of selecting wt1 vaccine adaptive patient
WO2005084134A2 (en) * 2004-03-04 2005-09-15 Dena Leshkowitz Quantifying and profiling antibody and t cell receptor gene expression
MX343633B (en) * 2007-03-05 2016-11-11 Int Inst Cancer Immunology Inc GENE RECEIVER OF T-CELL SPECIFICS OF CANCERIGENE ANTIGEN, PEPTIDE CODED BY THE GEN, AND USE OF THE SAME.
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
EP3699296A1 (en) 2008-11-07 2020-08-26 Adaptive Biotechnologies Corporation Methods of monitoring conditions by sequence analysis
US8691510B2 (en) 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
DK2387627T3 (en) 2009-01-15 2016-07-04 Adaptive Biotechnologies Corp Adaptive immunity profiling and methods for producing monoclonal antibodies
RU2539032C2 (en) 2009-06-25 2015-01-10 Фред Хатчинсон Кансэр Рисёч Сентер Method for measuring artificial immunity
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
AU2012276908A1 (en) 2011-06-28 2014-02-20 International Institute Of Cancer Immunology, Inc. Receptor gene for peptide cancer antigen-specific T cell
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
US9279159B2 (en) 2011-10-21 2016-03-08 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
CN102373206B (en) * 2011-10-31 2013-02-27 暨南大学 PPP2R5C-siRNA799 targeted to inhibit PPP2R5C gene expression and tumor T cell proliferation and its application
EP3388535B1 (en) 2011-12-09 2021-03-24 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
US10077478B2 (en) 2012-03-05 2018-09-18 Adaptive Biotechnologies Corp. Determining paired immune receptor chains from frequency matched subunits
US9150905B2 (en) 2012-05-08 2015-10-06 Adaptive Biotechnologies Corporation Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions
EP3330384B1 (en) 2012-10-01 2019-09-25 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CA2941612A1 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (en) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Quantification of adaptive immune cell genomes in a complex mixture of cells
ES2784343T3 (en) 2014-10-29 2020-09-24 Adaptive Biotechnologies Corp Simultaneous, highly multiplexed detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
AU2015353581A1 (en) 2014-11-25 2017-06-15 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
EP3591074B1 (en) 2015-02-24 2024-10-23 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
AU2016242967B2 (en) 2015-04-01 2021-07-01 Adaptive Biotechnologies Corp. Method of identifying human compatible T cell receptors specific for an antigenic target
JP2018526034A (en) * 2015-09-10 2018-09-13 アフィジェン・インコーポレイテッド Selection guided by tumor therapeutic drug sequencing
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US20020107388A1 (en) * 2000-05-12 2002-08-08 Vandenbark Arthur A. Methods of identifying and monitoring disease-associated T cells

Also Published As

Publication number Publication date
WO2003059155A3 (en) 2004-03-11
CN1688708A (en) 2005-10-26
WO2003059155A2 (en) 2003-07-24
AU2003207528A8 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
AU2003207528A1 (en) Method of detecting t-cell proliferation for diagnosis of diseases by gene array
AU2003210707A1 (en) Apparatus for synthesis of arrays of dna probes
AU2003256407A1 (en) Method of preparing high specific activity platinum-195m
AU2003301347A1 (en) Methods for monitoring treatment of disease
AU2003219689A1 (en) Method and system for risk-modulated diagnosis of disease
AU2003301564A1 (en) Method for improved diagnosis of dysplasias
AU2003247827A1 (en) Methods to assess quality of microarrays
AU2003280991A1 (en) Method for diagnosis of intestinal-type gastric tumors
AU2003273335A1 (en) Method for testing drug susceptibility of hiv
AU2003212822A1 (en) Methods for determining drug responsiveness
AU2003212245A1 (en) Method of diagnosis of inflammatory diseases using calgranulin c
AU2002952938A0 (en) System for Conducting Clinical Trials
AU2003206688A1 (en) Sensor comprising an array of piezoresistors
AU2003220034A1 (en) An early detection marker for chronic inflammatory associated diseases
AU2003212246A1 (en) Method for diagnosis of inflammatory diseases using mrp8/mrp14
AU2003223780A1 (en) Treatment for pompe disease
AU2003201630A1 (en) A method for the diagnosis of lymphoproliferative diseases
AU2003214560A1 (en) Test for measurement of therapeutic drug levels
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
AU2003289316A1 (en) Monitor protein for measuring processing of protein
AU2003294206A1 (en) Methods for diagnosing htlv-i-mediated diseases
AU2003293382A1 (en) Methods for identifying the activity of gene products
AU2003263728A1 (en) Method for diagnosis of cancer
AU2003298160A1 (en) High-throughput screening method for identifying active substances by means of co-cultivation
AU2003226492A1 (en) Support array for transducers

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase